Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoidsM. Caplin, Zeng Zheng-Pei, Aurel Perren et al.|Annals of Oncology|2015Cited by 698
Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)Enrique Grande, Rocio García‐Carbonero, Jaume Capdevila et al.|Annals of Oncology|2015Cited by 157
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor HypoxiaRodrigo A. Toledo, Patricia L. M. Dahia, Camilo Jiménez et al.|Endocrine Reviews|2022Cited by 86
Convergent genetic adaptation in human tumors developed under systemic hypoxia and in populations living at high altitudesCarlota Arenillas, Anna Casteràs, José Ruiz-Cantador et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 1